Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Tetrud

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Neurology|May 1, 1991
Preclinical Parkinson's disease: detection of motor and nonmotor manifestationsJ W Tetrud
Geriatrics|August 1, 1991
Preclinical detection of motor and nonmotor manifestationsJ W Tetrud
Science (New York, N.Y.)|August 4, 1989
The effect of deprenyl (selegiline) on the natural history of Parkinson's diseaseJ W Tetrud, J W Langston
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
MPTP-induced parkinsonism as a model for Parkinson's diseaseJ W Tetrud, J W Langston
Neurology|February 1, 1992
Tremor in MPTP-induced parkinsonismJ W Tetrud, J W Langston
Neurologic Clinics|May 1, 1992
Protective and preventive therapeutic strategies: monoamine oxidase inhibitorsJ W Tetrud, J W Langston
Journal of Neural Transmission. Supplementum|January 1, 1987
R-(-)-deprenyl as a possible protective agent in Parkinson's diseaseJ W Tetrud, J W Langston
Neurology|July 1, 1985
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven casesP A Ballard, J W Tetrud, J W Langston
Neurology|June 1, 1994
Parkinsonism caused by petroleum waste ingestionJ W Tetrud, J W Langston, I Irwin, et al.
Science (New York, N.Y.)|February 25, 1983
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesisJ W Langston, P Ballard, J W Tetrud, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Neurology|May 1, 1991
Preclinical Parkinson's disease: detection of motor and nonmotor manifestationsJ W Tetrud
Geriatrics|August 1, 1991
Preclinical detection of motor and nonmotor manifestationsJ W Tetrud
Science (New York, N.Y.)|August 4, 1989
The effect of deprenyl (selegiline) on the natural history of Parkinson's diseaseJ W Tetrud, J W Langston
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
MPTP-induced parkinsonism as a model for Parkinson's diseaseJ W Tetrud, J W Langston
Neurology|February 1, 1992
Tremor in MPTP-induced parkinsonismJ W Tetrud, J W Langston
Neurologic Clinics|May 1, 1992
Protective and preventive therapeutic strategies: monoamine oxidase inhibitorsJ W Tetrud, J W Langston
Journal of Neural Transmission. Supplementum|January 1, 1987
R-(-)-deprenyl as a possible protective agent in Parkinson's diseaseJ W Tetrud, J W Langston
Neurology|July 1, 1985
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven casesP A Ballard, J W Tetrud, J W Langston
Neurology|June 1, 1994
Parkinsonism caused by petroleum waste ingestionJ W Tetrud, J W Langston, I Irwin, et al.
Science (New York, N.Y.)|February 25, 1983
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesisJ W Langston, P Ballard, J W Tetrud, et al.
Pageof 3